We have been awarded a grant from Blood Cancer UK
- Mar 1, 2022
- 1 min read
Updated: Dec 9, 2022
The Blood Cancer UK grant supports us to investigate the role of host factors in establishing HTLV-1 infection, integration site selection and proviral expression.
Comments